TAKEDA PHARMACEUTICAL CO LTD

TAK - Company ID 0001395064

Market cap$24.43 B

Rank#549

Filings609

TAKEDA PHARMACEUTICAL CO LTD has filed 609 public company documents between 2007 and 2026. The most frequent type is 6-k (323 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchTAK overview$24.43 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #549See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut TAK beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow TAK via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
6-K	6-K	1y ago2024-12-18	2024-12-18	View filing
6-K	6-K	1y ago2024-12-13	2024-12-13	View filing
6-K	6-K	1y ago2024-12-02	2024-12-02	View filing
6-K	6-K	1y ago2024-10-31	2024-10-31	View filing
6-K	6-K	1y ago2024-10-31	2024-10-31	View filing
6-K	6-K	1y ago2024-10-31	2024-10-31	View filing
6-K	6-K	1y ago2024-09-26	2024-09-26	View filing
144	Insider sale notice	1y ago2024-08-22	-	View filing
SC 13G/A	Passive ownership stake (update)	1y ago2024-07-31	-	View filing
6-K	6-K	1y ago2024-07-31	2024-07-31	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
144	Insider sale notice	1y ago2024-07-10	-	View filing
6-K	6-K	1y ago2024-07-10	2024-07-10	View filing
6-K	6-K	2y ago2024-07-09	2024-07-09	View filing
6-K	6-K	2y ago2024-07-05	2024-07-05	View filing
6-K	6-K	2y ago2024-07-02	2024-07-02	View filing
6-K	6-K	2y ago2024-07-01	2024-07-01	View filing
424B2	Prospectus supplement	2y ago2024-06-28	-	View filing
FWP	Free writing prospectus	2y ago2024-06-28	-	View filing
424B5	Prospectus supplement	2y ago2024-06-27	-	View filing
F-3ASR	F-3ASR	2y ago2024-06-26	-	View filing
20-F	20-F	2y ago2024-06-26	2024-03-31	View filing
6-K	6-K	2y ago2024-06-26	2024-06-26	View filing
6-K	6-K	2y ago2024-06-26	2024-06-26	View filing
6-K	6-K	2y ago2024-06-17	2024-06-17	View filing
6-K	6-K	2y ago2024-06-11	2024-06-11	View filing
6-K	6-K	2y ago2024-06-10	2024-06-10	View filing
6-K	6-K	2y ago2024-06-07	2024-06-07	View filing
6-K	6-K	2y ago2024-06-07	2024-06-07	View filing
6-K	6-K	2y ago2024-06-03	2024-06-03	View filing
6-K	6-K	2y ago2024-06-03	2024-06-03	View filing
6-K	6-K	2y ago2024-05-29	2024-05-29	View filing
6-K	6-K	2y ago2024-05-29	2024-05-29	View filing
6-K	6-K	2y ago2024-05-29	2024-05-29	View filing
6-K	6-K	2y ago2024-05-29	2024-05-29	View filing
6-K	6-K	2y ago2024-05-21	2024-05-21	View filing
6-K	6-K	2y ago2024-05-09	2024-05-09	View filing
6-K	6-K	2y ago2024-05-09	2024-05-09	View filing
6-K	6-K	2y ago2024-05-09	2024-05-09	View filing
6-K	6-K	2y ago2024-05-09	2024-05-09	View filing

TAKEDA PHARMACEUTICAL CO LTD

Similar companies to research next

Year